Establishment of marrow mesenchymal stem cells expressing rat NKX2.5-pEGFP fusion protein
Liwei Zhao
Abstract
Liwei Zhao
Abstract
Objective To construct the rat NKX2.5-pEGFP fusion eukaryotic expression plasmid and screen bone marrow mesenchymal stem cells(MSCs) expressing rat fusion protein NKX2.5-pEGFP and provide theoretical foundation for the research of cell and gene therapy of myocardial infarction.Methods The total RNAs were extracted from myocardial cells of embryo rats,RT-PCR amplification was performed to produce rat gene of NKX2.5.The recombinant plasmid NKX2.5-pEGFP was obtained by inserting the aim gene into pEGFP-N3.The MSCs derived from bone marrow mononuclear cells were obtained by gradient centrifugation and adherent culture.The recombinant plasmids NKX2.5-pEGFP were transfected into rat MSCs by Lipo2000 and screened with G418 for 2 weeks.The expression of recombinant plasmid in MSCs was detected by Western blotting and fluoroscope analysis.Results The length of NKX2.5 gene obtained by RT-PCR was 981 bp which was consistent with theoretical numerus.The recombinant plasmid NKX2.5-pEGFP was identified by endonuclease digestion and PCR,which could be digested into two fragments with BamHⅠ and SalⅠ,about 981 and 4 700 bp,the results were coincident with the anticipated result.The protein with molecular weight of 65 000 was found in MSCs transfected with the recombinant plasmid NKX2.5-pEGFP by Western blotting which was coincident with theoretical numerus.Green fluorescence was positive expression in MSCs transfected with the recombinant plasmid NKX2.5-pEGFP by fluorescence detection.Conclusion The rat MSCs expressing NKX2.5-pEGFP fusion protein is successfully constructed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To construct the rat NKX2.5-pEGFP fusion eukaryotic expression plasmid and screen bone marrow mesenchymal stem cells(MSCs) expressing rat fusion protein NKX2.5-pEGFP and provide theoretical foundation for the research of cell and gene therapy of myocardial infarction.Methods The total RNAs were extracted from myocardial cells of embryo rats,RT-PCR amplification was performed to produce rat gene of NKX2.5.The recombinant plasmid NKX2.5-pEGFP was obtained by inserting the aim gene into pEGFP-N3.The MSCs derived from bone marrow mononuclear cells were obtained by gradient centrifugation and adherent culture.The recombinant plasmids NKX2.5-pEGFP were transfected into rat MSCs by Lipo2000 and screened with G418 for 2 weeks.The expression of recombinant plasmid in MSCs was detected by Western blotting and fluoroscope analysis.Results The length of NKX2.5 gene obtained by RT-PCR was 981 bp which was consistent with theoretical numerus.The recombinant plasmid NKX2.5-pEGFP was identified by endonuclease digestion and PCR,which could be digested into two fragments with BamHⅠ and SalⅠ,about 981 and 4 700 bp,the results were coincident with the anticipated result.The protein with molecular weight of 65 000 was found in MSCs transfected with the recombinant plasmid NKX2.5-pEGFP by Western blotting which was coincident with theoretical numerus.Green fluorescence was positive expression in MSCs transfected with the recombinant plasmid NKX2.5-pEGFP by fluorescence detection.Conclusion The rat MSCs expressing NKX2.5-pEGFP fusion protein is successfully constructed.
Key concepts: Molecular biology, Recombinant DNA, Mesenchymal stem cell, Transfection, Plasmid, Fusion protein, Western blot, Blot